Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help.

Vanguard says the next phase of the AI boom may favor developed non-U.S. equities over U.S. growth stocks, projecting developed ex-U.S. returns of 4.5%–6.5% annually vs 3.6%–5.6% for U.S. growth over the next 10 years. The article highlights two ETF options: State Street’s SPDW (2,436 stocks) with ~9.8% annualized returns over five years and a ~0.03% expense ratio, and Vanguard’s VYMI (1,565 stocks) with ~14.1% annualized returns over five years and a ~0.07% expense ratio. It also notes dividend yields of about 3.0% (SPDW) and 3.5% (VYMI) as of mid-August.

Analysis

This is less an AI trade than a valuation-and-margins trade: if AI begins showing up in non-U.S. operating leverage, the biggest winner is not the company selling the software, but the firms with large labor costs, lower starting multiples, and room for margin surprise. That points to developed ex-U.S. financials, industrials, pharma, and selected semicap equipment names as the first-order beneficiaries, with ASML still the cleanest “picks-and-shovels” proxy if global capex broadens beyond the U.S. hyperscaler set. The market is still pricing AI as a U.S. equity exceptionalism story; any credible evidence of diffusion would compress that narrative premium and lift non-U.S. earnings revisions.

The near-term risk is that this remains a consensus-friendly thesis with poor timing: a stronger dollar, renewed U.S. growth leadership, or another wave of hyperscaler capex would keep relative performance pinned to U.S. mega-cap tech for another 1-3 quarters. The more dangerous version of the trade is that ex-U.S. allocations are not pure AI exposure but a blended basket of banks, staples, energy, and quality cyclicals, so the upside depends on macro support plus productivity gains—not just sentiment. The falsifier is simple: if QQQ/XLK keep outgrowing global earnings by the next two reporting seasons, the rotation thesis is premature.

Contrarian angle: the market may be underestimating how much of the AI diffusion theme is already embedded in cheap ex-U.S. valuations, especially in dividend/value ETFs like VYMI. That argues for preferring a relative-value expression over outright longs, because the dividend sleeve will cushion drawdowns but also dilute upside if AI monetization stays concentrated in U.S. platform names. State Street’s fund itself is not the edge; the edge is the factor mix inside it and the likely weak-dollar tailwind if U.S. leadership broadens out.

Key Decisions for Investors

• Initiate a small relative-value long SPDW / short QQQ pair over the next 1-3 weeks; target 8-12% relative upside if ex-U.S. earnings revisions start to broaden, with a stop if QQQ re-accelerates on earnings leadership or DXY breaks materially higher.
• Prefer VYMI only as a satellite position, not a core AI expression; use it as a defensive carry sleeve while waiting for diffusion evidence, but size modestly because the bank/energy mix will lag if global rates back up.
• For a more targeted basket, go long ASML + NVS + RHHBY versus short NVDA on a 3-6 month horizon if you believe AI capex spills into global productivity but current U.S. AI multiples remain stretched; cover if NVDA guidance re-accelerates or ASML order commentary weakens.
• Set an alert for the next two rounds of European and Japanese earnings guidance: if management teams begin citing AI-driven labor leverage or margin expansion, add to ex-U.S. exposure; if not, treat the thesis as a narrative trade only.
• No direct trade in STT from this article alone; any ETF flow benefit is too diffuse to underwrite an active position without AUM/flow data.